| Date Filed | Type | Description |
| 07/06/2023 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 36.1% stake in RegeneRx Biopharmaceuticals, Inc. |
| 07/06/2023 |
4
| Essetifin SPA (10% Owner) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Bought options to buy
@ $50000, valued at
$0
Acquired 3,750,000 warrants
@ $0 |
|
| 07/02/2021 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 32.2% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 34.4% stake in RegeneRx Biopharmaceuticals, Inc. |
| 05/04/2020 |
4
| Essetifin SPA (10% Owner) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Bought 768,000 shares
@ $6.25, valued at
$4.8M
|
|
| 05/04/2020 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 16.2% stake in Fennec Pharmaceuticals Inc. |
| 05/16/2019 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 33.9% stake in RegeneRx Biopharmaceuticals, Inc. |
| 05/16/2019 |
4
| Essetifin SPA (10% Owner) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Bought options to buy
@ $500000, valued at
$0
Acquired 3,125,000 warrants
@ $0 |
|
| 03/01/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/01/2019 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31.2% stake in RegeneRx Biopharmaceuticals, Inc. |
| 02/27/2019 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31% stake in RegeneRx Biopharmaceuticals, Inc. |
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2018 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 28.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 03/14/2018 |
4
| Essetifin SPA (10% Owner) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Bought 11,584,795 shares
@ $0.23, valued at
$2.7M
Bought 6,348,878 shares
@ $0.23, valued at
$1.5M
Bought options to buy
@ $0.06, valued at
$0 |
|
| 03/14/2018 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 30.6% stake in RegeneRx Biopharmaceuticals, Inc. |
| 12/19/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/14/2017 |
4
| Essetifin SPA (10% Owner) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Bought 294,115 shares
@ $8.5, valued at
$2.5M
|
|
| 12/01/2017 |
4
| Essetifin SPA (Former 10% Owner) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Sold 271,140 shares
@ $2.12, valued at
$574.8k
Bought 271,140 shares
@ $2.12, valued at
$574.8k
Sold 5,954 shares
@ $2.12, valued at
$12.6k
Bought 5,954 shares
@ $2.12, valued at
$12.6k
Sold 16,416 shares
@ $2.12, valued at
$34.8k
Bought 16,416 shares
@ $2.12, valued at
$34.8k
|
|
| 12/01/2017 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 3.9% stake in Soligenix, Inc. |
| 10/04/2017 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 09/21/2017 |
3
| Essetifin SPA (10% Owner) has filed a Form 3 on FENNEC PHARMACEUTICALS INC. |
| 01/02/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 12/21/2012 |
4
| SIGMA TAU FINANZIARIA SPA (10% Owner) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Disposed of 1 warrants
@ $0
Acquired 1 warrants
@ $0.53, valued at
$0.5 |
|
| 10/25/2012 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31.6% stake in RegeneRx Biopharmaceuticals, Inc. |
| 05/02/2012 |
4
| SIGMA TAU FINANZIARIA SPA (10% Owner) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 6,328,469 shares
@ $5.25, valued at
$33.2M
Disposed/sold 252,469 shares
@ $5.25, valued at
$1.3M
|
|
| 05/02/2012 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 4.3% stake in SciClone Pharmaceuticals, Inc. |
| 07/18/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/14/2011 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 32.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 01/07/2011 |
4
| SIGMA TAU FINANZIARIA SPA (10% Owner) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Bought 925,926 shares
@ $0.27, valued at
$250k
Acquired 1 warrants
@ $0.38, valued at
$0.4
Disposed of 1 warrants
@ $4.06, valued at
$4.1
Disposed of 1 warrants
@ $2.75, valued at
$2.8 |
|
| 07/13/2010 |
SC 13D/A
| SCICLONE PHARMACEUTICALS INC reports a 20.8% stake in SciClone Pharmaceuticals, Inc. |
| 07/09/2010 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 06/28/2010 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 30.2% stake in Soligenix, Inc. |
|